Commentaries on Jackson et al. "Successful withdrawal of oral long-acting nitrates to facilitate phosphodiesterase type 5 inhibitor use in stable coronary disease patients with erectile dysfunction"

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of sexual medicine 2005-09, Vol.2 (5), p.740-742
Hauptverfasser:	Kloner, Robert A, Montorsi, Piero, DeBusk, Robert F
Format:	Artikel
Sprache:	eng
Schlagworte:	3',5'-Cyclic-GMP Phosphodiesterases Coronary Artery Disease - drug therapy Coronary Artery Disease - epidemiology Coronary Artery Disease - physiopathology Cyclic Nucleotide Phosphodiesterases, Type 5 Erectile Dysfunction - epidemiology Humans Male Nitro Compounds - administration & dosage Nitro Compounds - therapeutic use Phosphodiesterase Inhibitors - administration & dosage Phosphodiesterase Inhibitors - therapeutic use Phosphoric Diester Hydrolases - metabolism Severity of Illness Index Withholding Treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!